NCT05289141View on ClinicalTrials.gov

Interest in the Use of Nasal High-Flow Oxygen Therapy (OptiFlow™) in Secondary Transport of COVID-19 Positive Patients

CompletedOBSERVATIONAL
Enrollment

229

Participants

Timeline

Start Date

March 24, 2022

Primary Completion Date

April 25, 2022

Study Completion Date

April 25, 2022

Conditions
COVID-19
Interventions
DEVICE

Use of high flow nasal oxygen therapy

Use of high flow nasal oxygen therapy during secondary transport by emergency medical service 83 (SAMU 83).

DEVICE

Use of other non-invasive ventilation or high concentration oxygen masks

Use of other non-invasive ventilation or high concentration oxygen masks during secondary transport by emergency medical service 83 (SAMU 83).

Trial Locations (1)

83056

Centre Hopitalier Intercommunal Toulon - La Seyne sur Mer, Toulon

All Listed Sponsors
lead

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer

OTHER